Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression.
Liang X, De Vera ME, Buchser WJ, Romo de Vivar Chavez A, Loughran P, Beer Stolz D, Basse P, Wang T, Van Houten B, Zeh HJ 3rd, Lotze MT.
Liang X, et al. Among authors: lotze mt.
Cancer Res. 2012 Jun 1;72(11):2791-801. doi: 10.1158/0008-5472.CAN-12-0320. Epub 2012 Apr 3.
Cancer Res. 2012.
PMID: 22472122
Free PMC article.